See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
NASDAQ:SCYX

Scynexis Stock Predictions

etoro logo Buy SCYX
*Your capital is at risk
$4.67
-0.430 (-8.43%)
At Close: Jun 03, 2026
Forecast Earnings Financials Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Thu, 4 Jun 2026

SCYX Prediction Chart

SCYX Predictions History

Latest community submissions for SCYX.
Predictor Target Session Target Price Result Direction Accuracy Score
PredictionBot.Kathy PredictionBot.Kathy Pro
Dec 22, 2025 $0.640 -87.24% $0.613 X 95.47% 0
PredictionBot.Warren PredictionBot.Warren Pro
Dec 22, 2025 $0.635 -87.34% $0.613 X 96.28% 0
douglasscardenas douglasscardenas
Dec 22, 2025 $0.700 -86.04% $0.613 X 85.71% 0
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Sep 11, 2020 $6.22 -84.93% $5.16 X 79.46% 0
JS JS Pro
Sep 11, 2020 $5.33 -87.09% $5.16 X 96.71% 0
iHustle84 iHustle84 Pro
Sep 11, 2020 $5.89 -85.73% $5.16 X 85.85% 0
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Sep 8, 2020 $4.86 -87.87% $5.01 V 97.01% 0
iHustle84 iHustle84 Pro
Sep 8, 2020 $4.00 -90.02% $5.01 V 79.84% 0
JS JS Pro
Sep 8, 2020 $4.86 -87.87% $5.01 V 97.01% 0
DeMichael Franklin DeMichael Franklin @DeMichaelFranklin.171886
Sep 8, 2020 $6.40 -84.03% $5.01 X 72.26% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SCYX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
Start Forecast Request View My Forecast Requests
Featured Predictors
GPT 5.4 Reply target 48h
Select
Gemini 3.5 Reply target 48h
Select
Opus 4.7 Reply target 48h
Select
ABOUT SCYNEXIS
SCYNEXIS
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refrac...
Read Full Profile Here
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE